Karyopharm Therapeutics Inc.
NASDAQ:KPTI · NASDAQ Global Select
+$0.50 today
Vol 0.32M · Avg 0.86M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+108.24%
Period High
$10.09
Period Low
$3.77
Latest
$9.10
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
X4 Pharmaceuticals, Inc.
NASDAQ:XFOR
$377.28M
Mersana Therapeutics, Inc.
MRSN
$145.36M
Telomir Pharmaceuticals, Inc. Common Stock
TELO
$43.32M
FibroGen, Inc.
FGEN
$36.69M
INmune Bio, Inc.
INMB
$32.97M
Aligos Therapeutics, Inc.
ALGS
$32.67M
Barinthus Biotherapeutics plc
BRNS
$27.41M
Senti Biosciences, Inc.
SNTI
$25.24M
Medicus Pharma Ltd. Common Stock
MDCX
$7.44M
CEL-SCI Corporation
CVM
$7.42M
What is the latest KPTI filing?
The latest filing shown is SC 13G/A dated Jun 5, 2026.
How many recent filings does KPTI have?
Intrinsic Alpha currently shows 20 recent filings for KPTI.
Explore More
Continue the stock analysis
Jump to another research area for this company.